drugset / Trial / NCT00243464

Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

NCT00243464

Phase 3 Completed 300 enrolled LEO Pharma
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol plus betamethasone dipropionate gel is more effective than twice daily treatment of calcipotriol scalp solution in patients with scalp psoriasis. The primary outcome is patients with clear or minimal disease after 8 weeks treatment. Further the occurrence of relapse and rebound after end of treatment in patients with clear or minimal disease will be investigated.

Timeline

Start
2005-09
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule
Subject betamethasone dipropionate Small molecule

Indications